The effects of cardiac myocytes on interstitial fibroblasts in toxic iron overload.
Iron deposits preferentially in myocytes in mixed cultures of cardiac myocytes and nonmyocytic fibroblasts. In vivo, iron overload is associated with cardiac fibrosis. Therefore, we examined whether iron loading of cardiac myocytes in culture could trigger a response in nonmyocytes characteristic of a fibrogenic phenotype. We found that the nonmyocytes adopted a myofibroblast phenotype in culture. The rate of DNA synthesis (measured by [3H]thymidine incorporation) by the nonmyocytes was decreased by the myocyte-conditioned medium, compared to that of the unconditioned medium, and this activity was retained in <10-kDa fractions. The rate was partially restored when the medium was obtained from iron-loaded myocytes, and in this medium, the <10-kDa fraction was even more effective in reversing the suppression of proliferation. This suppression suggests a decreased secretion of a growth inhibitory substance in the iron-loaded myocytes, and this effect was partially reversed when the iron-loaded cells were treated with the iron chelator, deferoxamine. This indicates that cardiac myocytes may play a paracrine role in suppressing the proliferation of myofibroblasts that is partially overcome when the myocytes are iron overloaded. The myocyte-conditioned medium also affects the myofibroblast phenotype, increasing the cells' fibronectin mRNA content and decreasing alpha-smooth-muscle actin mRNA. The myocyte-conditioned medium increases transforming growth factor-beta (TGF-beta) secretion by myofibroblasts, but the TGF-beta content of the conditioned medium was found to play, at most, a minor role in determining the response of the myofibroblast.
Liu
Y
Y
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
Templeton
D M
DM
D000818:Animals; D002450:Cell Communication / Q000187:drug effects; D002478:Cells, Cultured; D017077:Culture Media, Conditioned; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D005786:Gene Expression Regulation; D006321:Heart / Q000187:drug effects*; D007150:Immunohistochemistry; D007501:Iron / Q000378:metabolism / Q000506:poisoning*; D009206:Myocardium / Q000166:cytology* / Q000378:metabolism; D010641:Phenotype; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016212:Transforming Growth Factor beta / Q000378:metabolism
D017077:Culture Media, Conditioned; D016212:Transforming Growth Factor beta; D007501:Iron